CenterWatch announced a new service designed to assist biopharmaceutical companies and contract research organizations (CROs) in identifying and engaging investigative sites worldwide to conduct phase I through IV clinical trials.
Over the past several years, clinical research sponsors have become increasingly interested in recruiting skilled and active investigators from a larger and more diverse number of global regions. During this same period, the number of investigative sites exiting the clinical research enterprise has grown, as sites find it increasingly difficult to secure study grants. The new CenterWatch ‘Grant Notification Service’ is designed to match clinical research sponsors with currently active, experienced investigative sites and to provide an effective study grant generation tool for research professionals.
The service will be largely automated through the CenterWatch web site at www.centerwatch.com/trialwatch_signup and free of charge to use. By the end of September 2010, CenterWatch anticipates having 25,000 active global investigative sites registered on the service. In addition, CenterWatch anticipates handling three to five unique requests weekly from sponsor and CRO companies. Each specific request will generate a list of selected investigative sites to be contacted by the sponsor or CRO originating the request.
“We’re very pleased to be offering a new web-based service to the global investigative site community,” said Joan Chambers, CenterWatch Chief Operating Officer. “Our company has a long history of offering sites the opportunity to identify and secure study grants through our publications. We’re also excited to be providing sponsors and CROs with a quick and efficient way to identify and to ultimately contact viable investigative sites worldwide.”
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
The State of the Opioid Epidemic
March 26th 2024In part 1 of this video interview, Greg Sturmer, co-founder and CEO of Elysium Therapeutics discusses the current state of opioid usage including how pain treatment is often mismanaged and how the industry can adopt greater safety standards in developing pain therapies.